MHMohamad Hamad

Mohamad Hamad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohamad Hamad has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multi-Omics Profiling of Candida albicans Grown on Solid Versus Liquid Media

    by Rouba Abdulsalam Alhameed, Mohammad H. Semreen, Mohamad Hamad, Alexander D. Giddey, Ashna Sulaiman, Mohammad T. Al Bataineh, Hamza M. Al-Hroub, Yasser Bustanji, Karem H. Alzoubi, Nelson C. Soares

    Candida albicans is a common pathogenic fungus that presents a challenge to healthcare facilities. It can switch between a yeast cell form that diffuses through the bloodstream to colonize internal organs and a filamentous form that penetrates host mucosa. Understanding the pathogen’s strategies for environmental adaptation and, ultimately, survival, is crucial. As a complementary study, herein, a multi-omics analysis was performed using high-resolution timsTOF MS to compare the proteomes and metabolomes of Wild Type (WT) Candida albicans (strain DK318) grown on agar plates versus liquid media. Proteomic analysis revealed a total of 1793 proteins and 15,013 peptides. Out of the 1403 identified proteins, 313 proteins were significantly differentially abundant with a p-value < 0.05. Of these, 156 and 157 proteins were significantly increased in liquid and solid media, respectively. Metabolomics analysis identified 192 metabolites in total. The majority (42/48) of the significantly altered metabolites (p-value 0.05 FDR, FC 1.5), mainly amino acids, were significantly higher in solid media, while only 2 metabolites were significantly higher in liquid media. The combined multi-omics analysis provides insight into adaptative morphological changes supporting Candida albicans’ life cycle and identifies crucial virulence factors during biofilm formation and bloodstream infection.


  • Open Access

    Antimicrobial activity of nature-inspired molecules against multidrug resistant bacteria

    by Mohamad Hamad, Farah Al-Marzooq, Vunnam Srinivas, Ashna Sulaiman, Taleb H. Al-Tel

    Multidrug-resistant bacterial infections present a serious challenge to global health. In addition to the spread of antibiotic resistance, some bacteria can form persister cells which are tolerant to most antibiotics and can lead to treatment failure or relapse. In the present work, we report the discovery of a new class of small molecules with potent antimicrobial activity against Gram-positive bacteria and moderate activity against Gram negative drug resistant bacterial pathogens. The lead compound SIMR 2404 had a minimal inhibitory concentration (MIC) of 2 µg/ml against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-intermediate Staphylococcus aureus (VISA). The MIC values against Gram negative bacteria such as Escherichia coli and Actinobacteria baumannii were between 8–32 µg/ml. Time kill experiments show that compound SIMR 2404 can rapidly kill tested bacteria. Compound SIMR 2404 was also found to rapidly kill MRSA persisters which display high levels of tolerance to conventional antibiotics. In antibiotic evolution experiments, MRSA quickly developed resistance to ciprofloxacin but failed to develop resistance to compound SIMR 2404 even after 24 serial passages. The rapid antibacterial activity against both active and persister MRSA and to a lesser extent against Gram negative bacteria, suggest the potential of these molecules for further evaluation as antibacterial agents.

  • Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise

    by Noura Khaiwa, Noor R. Maarouf, Mhd H. Darwish, Dima W.M. Alhamad, Anusha Sebastian, Mohamad Hamad, Hany A. Omar, Gorka Orive, Taleb H. Al-Tel


  • Superbugs but no drugs: steps in averting a post-antibiotic era

    by Mohamad Hamad, Farah Al-Marzooq, Gorka Orive, Taleb H. Al-Tel